Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

Biotechnology • Healthcare • Huntsville, AL, United States • SER (ASE)

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.

256 327 9630 601 Genome Way, Huntsville, AL 35806, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Top Serina Therapeutics Insider Makes a Sudden Move With Company Stock - TipRanks
TipRanks • Dec 24
Serina Therapeutics Stock Slumps Pre-Market After FDA Places Hold On Application To Initiate Clinical Trials For Experimental Therapy - Stocktwits
Stocktwits • Nov 3
Serina Therapeutics Holds 2025 Annual Stockholders Meeting - MSN
MSN • Dec 12
Moreadith of Serina Therapeutics sells shares worth $15,167 By Investing.com - Investing.com Nigeria
Investing.com Nigeria • Dec 23
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry - GlobeNewswire
GlobeNewswire • Dec 11

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Serina Therapeutics, Inc. had layoffs?
No layoff events have been recorded for Serina Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Serina Therapeutics, Inc. have?
Serina Therapeutics, Inc. has approximately 12 employees.
What industry is Serina Therapeutics, Inc. in?
Serina Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Serina Therapeutics, Inc. a publicly traded company?
Yes, Serina Therapeutics, Inc. is publicly traded under the ticker symbol SER on the ASE. The company has a market capitalization of approximately $0.03 billion.
Where is Serina Therapeutics, Inc. headquartered?
Serina Therapeutics, Inc. is headquartered in Huntsville, AL, United States at 601 Genome Way, Huntsville, AL 35806, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.